Evidence map›Paper›PMID 40927540›Full record

ArticleERJ open research2025

Enhancing diagnostic precision: a multicentric study of endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy in lymphoproliferative disorders.

Miguel Ariza-Prota, Javier Pérez-Pallarés, Emanuela Barisione, Juan José Cruz-Rueda, Sammy Onyancha, Daniela Usturoi, Michele De Santis, Esperanza Salcedo-Lobera, Diego Ferrer-Pargada, Nadia Corcione and 7 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Miguel Ariza-ProtaDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID https://orcid.org/0000-0001-7183-2646
Javier Pérez-PallarésDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Santa Lucía, Cartagena, Spain.
Emanuela BarisioneDivision of Respiratory Medicine, Interventional Pulmonology Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy.
Juan José Cruz-RuedaDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Torrecárdenas, Almería, Spain.
Sammy OnyanchaDivision of Respiratory Medicine, Interventional Pulmonology Unit, St. Elisabeth Hospital, Frankfurt, Germany.ORCID https://orcid.org/0009-0002-5774-074X
Daniela UsturoiDivision of Respiratory Medicine, Interventional Pulmonology Unit, Foch Hospital, Suresnes, France.
Michele De SantisDivision of Respiratory Medicine, Interventional Pulmonology Unit, Instituto Portugês de Oncología de Coimbra, Coimbra, Portugal.
Esperanza Salcedo-LoberaDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.
Diego Ferrer-PargadaDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Marqués de Valdecilla, Santander, Spain.ORCID https://orcid.org/0000-0001-9088-5946
Nadia CorcioneDivision of Respiratory Medicine, Interventional Pulmonology Unit, Azienda Ospedaliera Di Rilievo Nazionale Antonio Cardarelli, Naples, Italy.
Alberto Caballero-VázquezDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Vírgen de las Nieves, Granada, Spain.
Ignacio Rodríguez-BlancoDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario de Badajoz, Badajoz, Spain.
Héctor Torres-RivasDivision of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID https://orcid.org/0000-0003-0154-5240
Luis Fernández-FernándezDivision of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain.
Francisco Javier Velasco-AlbendeaDepartment of Pathology, Hospital Universitario Torrecárdenas, Almería, Spain.ORCID https://orcid.org/0000-0002-2687-4289
Marta García-ClementeDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.ORCID https://orcid.org/0000-0003-0463-5946
Francisco López-GonzálezDivision of Respiratory Medicine, Interventional Pulmonology Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the diagnosis of lymphoma has a low overall sensitivity. The lack of tissue architecture obtained by cytological needles decreases the diagnostic accuracy for diagnosis and subtyping of Methods: A multicentre retrospective observational study conducted on 40 patients who underwent both EBUS-TBNA and EBUS-TMC in the same procedure in which a definitive diagnosis of lymphoma was obtained from January 2023 to January 2024. EBUS-TBNA and EBUS-TMC were performed in the same lymph node station. Results: The overall sensitivity of EBUS-TMC was significantly higher compared to EBUS-TBNA alone and EBUS-TBNA+flow cytometry (95% Conclusions: EBUS-TMC demonstrates superior sensitivity compared to EBUS-TBNA in diagnosing and subtyping lymphoma, both in suspected new cases and recurrences. This technique reduces the need for procedural repetitions and avoids more invasive and costly interventions such as mediastinoscopy.

Identifiers

PMID40927540
PMCPMC12415727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.